Maternal Immune Activation: Implications for Congenital Heart Defects

Area of Science:

• Developmental Biology
• Immunology
• Cardiovascular Research

Background:

• Congenital heart defects (CHD) are the most common major birth defects and a leading cause of infant mortality.
• The maternal immune activation (MIA) hypothesis links maternal immune responses during pregnancy to offspring neurodevelopmental and other health issues.
• Immune cells and cytokines are crucial for normal embryonic heart development.

Purpose of the Study:

• To explore the potential role of maternal immune activation (MIA) in the development of congenital heart defects (CHD).
• To identify knowledge gaps regarding the MIA-CHD relationship and stimulate further research.
• To review the impact of MIA in the context of pregnancy complications, maternal diseases, infections, and environmental factors.

Main Methods:

• This study is a review evaluating existing literature on MIA and CHD.
• It examines mechanisms involving immune cells, cytokines, placental development, and oxidative stress.
• The review synthesizes information on maternal and embryonic cardiac immuno-microenvironmental factors.

Main Results:

• Maternal immune activation can influence embryonic heart development through indirect regulation of the placental and cardiac immuno-microenvironment.
• Inflammatory cytokines associated with MIA can cross the placenta, inducing oxidative stress in the developing embryonic heart.
• Maternal factors, particularly immune status, play a critical role in embryonic heart development and CHD pathogenesis.

Conclusions:

• Maternal immune activation is a significant factor in the pathogenesis of congenital heart defects.
• Understanding the embryonic cardiac immuno-microenvironment is crucial for comprehending CHD development.
• Insights into MIA provide potential avenues for prenatal prevention and treatment strategies for CHD.